Analysis of Databases from Health Care Systems or Large Epidemiologic Studies to Evaluate Safety of Testosterone Administration in Older Men (R01)

The summary for the Analysis of Databases from Health Care Systems or Large Epidemiologic Studies to Evaluate Safety of Testosterone Administration in Older Men (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Analysis of Databases from Health Care Systems or Large Epidemiologic Studies to Evaluate Safety of Testosterone Administration in Older Men (R01)
	CFDA Number:	93.866
	CFDA Description:	Aging Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AG-12-007
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Jul 28, 2011
	Creation Date:	Jul 28, 2011
	Original Closing Date for Applications:	Nov 02, 2011
	Current Closing Date for Applications:	Nov 02, 2011
	Archive Date:	Dec 03, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	650,000
	Federal Grant Award Ceiling:	150,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Grant Description: This FOA solicits R01 projects that aim to evaluate the safety of testosterone administration in older men by assessing the relationship of testosterone administration to adverse outcomes in clinical practice. Applicants are encouraged to submit applications to conduct analyses of databases from health care systems or epidemiologic studies that contain information on diagnoses, therapies, and testosterone levels. Additional information on safety of testosterone administration is needed because, although several small short-term clinical trials have been conducted in older men, these studies do not provide adequate information to assess the safety of testosterone as used in clinical practice. This information is important for clinicians and their older patients in decisions regarding starting or continuing testosterone therapy. Moreover, adequate information on safety is lacking in regard to many important adverse outcomes, particularly in regard to long-term testosterone use.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-ag-12-007.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • T2 Translational Research: Research leading to new health care practices, community programs and pol...; • T1 Translational Research: Novel interventions for prevention and treatment of age-related condition...; • Social and Behavioral Research on the Elderly in Disasters (R03); • Network Infrastructure Support for Emerging Areas of Research in the Basic Biology of Aging (R24); • Leveraging Existing Data or Longitudinal Studies to Evaluate Safety and Effectiveness of Pharmacolog...; • Technological Enhancements and Archiving for Surveys of the Elderly: SBIR (R43/44) Initiative; • Technological Enhancements and Archiving for Surveys of the Elderly: STTR (R41/42) Initiative; • Technology and Aging: NIA Small Business Technology Transfer Program Initiative (STTR [R41/R42]); • Technology and Aging: NIA Small Business Innovation Research Program Initiative (SBIR [R43/R44]); • ACUTE CORONARY SYNDROMES IN OLD AGE